NewAmsterdam Pharma grants 106,600 share options to six new hires
NAMS•NewAmsterdam Pharma granted six non-executive new hires options covering 106,600 ordinary shares and restricted stock units covering 28,295 shares, dated November 2, 2026.
1. Award vesting terms
The options vest over four years, with 25% vesting on the first anniversary and the remainder in 36 equal monthly installments. The restricted stock units vest in thirds on each annual anniversary over three years. Vesting of both awards depends on continued service.
